SCHEMBL3270913

SCHEMBL3270913

CCCOS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219170 0.83
SCHEMBL2791299 0.81 CA1 (0.60)
Fluoride SCHEMBL27620657 0.81 CA1 (0.56)
SCHEMBL8720601 0.81 CA1 (0.33)
SCHEMBL8411185 0.79 CA1 (0.61)
SCHEMBL29137295 0.79 CA1 (0.61)
SCHEMBL5265837 0.79 CA1 (0.61)
SCHEMBL11510742 0.79 CA1 (0.61)
SCHEMBL10478711 0.79 CA1 (0.61)
SCHEMBL11791936 0.76 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4156058-A LITHIUM ANODE, ORGANIC SULFOHALOGENIDE SOLVENT VARTA BATTERIE A.G. (DE) 1979-05-22 US claimed
US-9920042-B2 Compounds for use in the treatment of mycobacterial infections UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2018-03-20 US disclosed
CN-104496901-B The manufacture method of anthranilamide compound ISHIHARA SANGYO KAISHA, LTD. (JP) 2016-05-25 CN disclosed
US-20150225388-A1 COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS UNIVERSITE DE DROIT ET DE LA SANTE DE LILLE 2 (FR) 2015-08-13 US disclosed
CN-102826966-B Preparation method for liquid crystal monomer of o-difluoroalkoxybenzene derivative YANTAI VALIANT FINE CHEMICALS CO LTD 2014-11-26 CN disclosed
CN-102826966-A Preparation method for liquid crystal monomer of o-difluoroalkoxybenzene derivative VALIANT FINE CHEMICALS CO LTD 2012-12-19 CN disclosed
CN-1854133-B Heterocycle-bearing onium salts WAKO PURE CHEM IND LTD 2010-11-10 CN disclosed
EP-0951295-B1 COMPOSITIONS FOR USE IN INHIBITING OF ALPHA-V-BETA3 MEDIATED ANGIOGENESIS SCRIPPS RESEARCH INST (US) 2010-06-09 EP disclosed
CN-101589041-A Nitrogen-containing heterocyclic compounds and methods of use thereof SCHERING CORP (US) 2009-11-25 CN disclosed
CN-100475803-C Heterocyclic onium salt WAKO PURE CHEM IND LTD (JP) 2009-04-08 CN disclosed
EP-0844874-A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 1998-06-03 EP disclosed
WO-1997045447-A9 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS 1998-03-12 WO disclosed
WO-1997045137-A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ANGIOGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-12-04 WO disclosed
WO-1997045447-A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-12-04 WO disclosed
WO-1997006791-A9 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS 1997-04-03 WO disclosed
WO-1997006791-A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 1997-02-27 WO disclosed
EP-0589932-A1 SULPHONYL FORMAMIDRAZONES, METHODS OF PREPARING THEM, AGENTS CONTAINING THEM, AND THEIR USE AGAINST PLANT PESTS Hoechst Schering AgrEvo GmbH (DE) 1994-04-06 EP disclosed
WO-1992022526-A1 SULPHONYL FORMAMIDRAZONES, METHODS OF PREPARING THEM, AGENTS CONTAINING THEM, AND THEIR USE AGAINST PLANT PESTS HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-23 WO disclosed
EP-0518215-A1 Sulfonylformamidrazones, process for their preparation, medium containing them, and their use as herbicides Hoechst Schering AgrEvo GmbH (DE) 1992-12-16 EP disclosed
US-4156058-A LITHIUM ANODE, ORGANIC SULFOHALOGENIDE SOLVENT VARTA BATTERIE A.G. (DE) 1979-05-22 US disclosed